Tci Wealth Advisors, Inc. Celldex Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$34.78 - $47.43 $5,947 - $8,110	171 New	171 $6,000
Q2 2022 Jul 19, 2022	SELL	$20.5 - $37.33 $4,018 - $7,316	-196 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$27.64 - $39.32 $829 - $1,179	-30 Reduced 13.27%	196 $7,000
Q4 2021 Jan 24, 2022	BUY	$35.68 - $56.27 $2,461 - $3,882	69 Added 43.95%	226 $9,000
Q3 2021 Oct 29, 2021	BUY	$28.95 - $55.99 $4,545 - $8,790	157 New	157 $8,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.